Industry Report: Data-Backed Flu & Trials for Rare Disorders
Data-driven guidance for families: managing flu season with rare immune disorders, accessing compassionate use for orphan drugs, back-to-school planning, and joining natural history studies to speed treatments.
Robert Maxwell
Sep 24, 2025
orphan drug access
natural history studies
gene therapy trials
rare pediatric disorders